Related Experiment Video
Updated: Jun 6, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
Human type-1 angiotensin II (AT1) receptor gene structure and function
1Institut National de la Santé et de la Recherche Médicale U36, Chaire de Médecine Expérimentale, Collège de France, Paris, France.
The type-1 angiotensin II (AngII) receptor (AT(1)) gene expression is regulated by alternative splicing. Specific exon inclusions alter translation efficiency and receptor isoform production, impacting hypertension and cardiac failure treatments.
Area of Science:
- Molecular biology
- Cardiovascular research
- Pharmacology
Background:
- The type-1 angiotensin II (AngII) receptor (AT(1)) is a key drug target for hypertension and cardiac failure.
- Understanding AT(1) receptor expression regulation is crucial for therapeutic development.
Purpose of the Study:
- To investigate the mechanisms regulating the expression of the human AT(1) receptor gene.
- To analyze the role of alternative splicing in AT(1) receptor mRNA production and translation.
Main Methods:
- Analysis of human AT(1) gene pre-mRNA structure and alternative splicing.
- In vitro and in vivo studies of mRNA translation efficiency.
- Functional characterization of AT(1) receptor isoforms in transfected cells.
Main Results:
- The AT(1) gene produces mature mRNA through alternative splicing of five exons.
- Inclusion of exon 2 significantly inhibits translation, despite its presence in up to 50% of AT(1) mRNA.
- Transcripts with exon 3 spliced to exon 5 encode a functional longer AT(1) receptor isoform, present in up to one-third of total AT(1) mRNA.
Conclusions:
- Alternative splicing patterns are critical for regulating AT(1) receptor expression.
- Understanding splicing variants is essential alongside promoter activity and RNA stability for studying AT(1) gene regulation.
More Related Videos
09:51Live Cell Imaging and 3D Analysis of Angiotensin Receptor Type 1a Trafficking in Transfected Human Embryonic Kidney Cells Using Confocal Microscopy
Published on: March 27, 2017
07:21Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice
Published on: September 28, 2015
Related Concept Videos
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Antihypertensive Drugs: Action of β1 Blockers